New diabetes pill tested in humans for first time
NCT ID NCT05579314
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This early-stage study tested an experimental oral drug called XW014 in 127 healthy volunteers and people with type 2 diabetes. The main goal was to check if the drug is safe and how the body processes it. Researchers gave single or multiple doses and looked for side effects, changes in lab values, and how food affects the drug. This is a first step to see if XW014 might help control diabetes in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON - Early Development Services
Lenexa, Kansas, 66219, United States
-
ICON - Early Development Services
San Antonio, Texas, 78209, United States
-
ICON - Early Development Services
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.